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ABSTRACT
Objectives: Alcohol abuse leads to several diseases and millions of death worldwide. High-fat diet (HFD) is major contributor of non-alcoholic liver 
diseases and obesity. Combined consumption of HFD and alcohol has deleterious effect on blood cells. This study was carried out to evaluate the 
protective effect of rutin against combined consumption of HFD and alcohol-induced hematological alterations.
Methods: HFD 30% and ethanol 10% were administered for 4 weeks for induction of toxicity. Rutin (10, 20, and 40 mg/kg) and 50 mg/kg dose of 
silymarin were administered along with HFD and alcohol for 4 weeks.
Results: Combined consumption of HFD and alcohol increased mean corpuscular volume, total leukocytes count, eosinophil and monocyte, and 
decreased hematocrit and platelets. Administration of rutin improved hematological variables altered by HFD and alcohol consumption.
Conclusion: The present study concluded that administration of rutin may alleviate HFD and alcohol-induced hematological alterations by scavenging 
free radicals generation.
Keywords: High-fat diet, Alcohol, Rutin, Red blood cell, White blood cell.
INTRODUCTION
In the current century, modernization and busy lifestyle promote the 
consumption of fast food and alcohol which leads to several health, 
economic, and societal problems. Consumption of high-fat diet (HFD) is 
one of the most important factors of excessive accumulation of fat in liver 
leading to metabolic disorder. Studies on non-alcoholic fatty liver disease 
(NAFLD) reported in which liver hypertrophy is initiated by accumulation 
of fat resulting increased oxidative stress [1]. Over 3 million deaths were 
reported in 2012 due to alcohol consumption, corresponding to 5.9% 
of the global or one in every 20 deaths worldwide [2]. Intake of alcohol 
induces expression and activity of cytochrome P4502E1 (CYP2E1) 
enzyme leads to conversion of ethanol to acetaldehyde. This activity of 
CYP2E1 enzyme needs oxygen activation, resulting in overproduction of 
reactive oxygen species (ROS), for example, hydrogen peroxide, hydroxyl 
radical, and superoxide anion radical, elevated ROS generation, along 
with the exhaustion or inhibition of endogenous non-enzymatic and 
enzymatic antioxidant by ethanol, can lead to oxidative stress in body 
and subsequent tissue damage [3].
Antioxidant supplements are one of the possible strategies for 
maintaining redox homeostasis through directly quenching excessive 
ROS or defending endogenous antioxidative enzyme activities against 
oxidative stress [4]. Polyphenolic compounds including flavonoids 
and phenolic acids functions as antioxidant, antihyperglycemic, and 
antihypertensive agent [5]. Rutin, also known as Vitamin P, is one of the 
major flavonoids and presents in onions, apples, tea, and red wine. It 
has antiviral, antihypertensive, antioxidant [6], antibacterial, antitumor, 
anti-inflammatory, antidiarrheal, antiulcer, antimutagenic, vasodilator, 
immunomodulatory, and hepatoprotective activities [7,8].
Till now, there is no scientific report on protective effect of rutin against 
combined consumption of HFD and alcohol-induced hematological 
deviations. Therefore, the present investigation was an attempt to 
evaluate ameliorating effect of rutin against HFD and alcohol-induced 
hematological abnormalities in rats.
METHODS
Animals and chemical
Female albino Wistar rats (160±10 g) were obtained from Defense 
Research and Development Establishment, Gwalior, and acclimatized 
in departmental animal facility under standard husbandry 
conditions (25±2°C temperature, 60–70% relative humidity, and 
12 h photoperiod). Rats were fed with standard diet (Pranav Agro 
Industries, India) and water ad libitum. Experiments were conducted 
in accordance with the guidelines set by the Committee for the Purpose 
of Control and Supervision of Experiments on Animals (CPCSEA), India, 
and experimental protocols were approved by the institutional animal 
ethics committee (994/ERe/GO/06/CPCSEA). Rutin, silymarin, and 
other chemicals were procured from Sigma-Aldrich, Ranbaxy, and Hi-
Media Laboratories Ltd., India, ERBA Diagnostics, Germany. HFD was 
procured from VRK Nutritional Solutions, Pune (India).
Experimental design
4 weeks duration of exposure to HFD and alcohol was selected 
from our previous studies to induce hepatorenal disorder 
(Communicated). 42 animals were divided into seven groups of six 
animals each as follows: Group 1 and 2 received regular diet and 
water. Group 1 received vehicle according to body weight and served 
as control. Group 2 received rutin per se (40 mg/kg, p.o.) for 4 weeks 
(5 days in a week). Groups 3–7 received 30% HFD and 10% alcohol 
simultaneously and Group 3 served as experimental control. Group 4, 
5, 6, and 7 were treated individually with rutin at different doses of 
10 mg/kg, 20 mg/kg, and 40 mg/kg and silymarin (50 mg/kg, p.o.) 
considering 5 days in a week respectively. Animals of all the groups 
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were euthanized after 4 weeks of experiment; blood was collected for 
hematological analysis.
Hematological analysis
Red blood cell (RBC), red cell distribution width (RDW), hematocrit 
(HCT), mean corpuscular volume (MCV), hemoglobin, mean 
corpuscular hemoglobin (MCH), MCH concentration (MCHC), platelets, 
platelet distribution width (PDW), mean platelet volume (MPV), total 
leukocytes count (TLC), monocyte, eosinophil, and lymphocyte were 
done by blood analyzers manual instruction guide.
Statistical analysis
Data were expressed as mean ± standard error of six animals used 
in each group. Statistical analysis was carried out using one-way 
analysis of variance considering significant at 5% level followed by 
Student’s t-test considering statistically significant at p≤0.05 and 
p≤0.01 [9].
RESULTS
4 weeks combined consumption of HFD and alcohol did not cause 
significant alteration in RBC count and RDW. HFD and alcohol 
consumption significantly decreased HCT and increased MCV (p ≤0.05) 
as compared to control. Administration of 20 and 40 mg/kg doses 
of rutin and 50 mg/kg dose of silymarin improved HCT count at 5% 
level of significance. MPV was improved only at 40 mg/kg dose of rutin 
(p≤0.05) (Table 1).
Hemoglobin, MCH, and MCHC were not affected significantly after 
4 weeks combined consumption of HFD and alcohol (Table 2).
Eosinophil, monocyte count, and TLC were significantly (p≤0.01) 
increased after 4 weeks combined consumption of HFD and alcohol, 
but lymphocytes were not affected significantly by HFD and alcohol 
consumption. Administration of rutin 20 and 40 mg/kg improved TLC 
at (p≤0.05; p≤0.01), respectively. Monocytes count was decreased 
toward control at all the doses of rutin in a dose-dependent manner 
(p≤0.05; p≤0.01). Administration of rutin improved eosinophil count at 
higher dose only at 1% level of significance. Positive control silymarin 
50 mg/kg was also improved TLC, monocyte, and eosinophil at 5% level 
and 1% level of significance, respectively (Table 3).
4 weeks combined consumption of HFD and alcohol did not alter 
PDW and MPV significantly. HFD and alcohol decreased platelets 
count significantly at p≤0.05. The highest dose of rutin 40 mg/kg and 
silymarin 50 mg/kg increased platelets count significantly (p≤0.05; 
Table 4).
DISCUSSION
Alcohol abuse is a rising epidemic in India, especially among men, 
and nowadays, it is becoming a major problem with young adults. The 
clinical manifestations of alcohol-induced hematological disorders are 
profoundly influenced by the patient’s social and economic status and 
other factors such as nutritional deficiency or alcoholic cirrhosis. Most 
of these changes may severely affect either directly or indirectly and 
may cause anemia; however, a patient with extensive liver disease may 
develop an abnormally functioning fibrinogen or other coagulation 
disorders, which may initiate or exacerbate bleeding [10]. In modern 
century, people prefer to a sedentary lifestyle and a lack of exercise 
which are associated with increased prevalence of diabetes mellitus, 
obesity, hypertension, and hypertriglyceridemia. These are considered 
to be important causes of NAFLD and its more destructive form, 
i.e., non-alcoholic steatohepatitis [11,12].
Blood is a connective tissue which consists of fluid portions or 
plasma that is suspended by some formed elements (erythrocytes, 
leukocytes, and thrombocytes). Blood provides the basic connections 
between the organs and cells of the body and maintains a constant 
cellular environment by circulating through every tissue providing 
nutrients to them and eliminating waste products [13,14]. The 
4 weeks combined consumption of HFD and alcohol caused 
significant changes in hematological variables of animals. During 
the metabolism of alcohol and HFD, generation of ROS takes places 
leading to tissue and cells damage. Previous reports suggested that 
ethanol intake may lead to oxidative damage to erythrocytes and 
other tissues [15].
Chronic drinking of alcohol changes RBC in many aspects not only 
regarding changes in size of RBC (macrocytosis) but also even the 
presence of defective RBC in the blood and their production from the 
bone marrow [16]. As a result of these changes, anemia is a common 
found in alcoholics [16]. In the present finding, HFD and alcohol 
consumption did not alter the RBC, hemoglobin, MCH, and MCHC, due 
to low concentration of alcohol and also may be short time duration 
of consumption. Devi and Rajkumar reported that in hyperlipidemic 
condition RBC and hemoglobin were not altered significantly in 
rats [17].
In case of tissue damage or inflammation, the platelets stick to 
the lesions of the blood vessels and adhere to exposed endothelial 
tissues [18]. The HCT is one of the key factors influencing platelet 
adherence to the vessel wall, and the elevation of the HCT causes 
rise in platelet accumulation [19]. Reduction of platelets count is 
associated with thrombocytopenia. In the present study, HFD and 
alcohol consumption decreased platelets count and HCT. The finding 
is in agreement with previous reports [20-22]. Rutin administration 
increased platelet count and HCT, which indicate the ability of rutin 
to ameliorate bleeding tendencies. Previous finding showed that the 
rutin improved platelet count against doxorubicin [23]. The MCV 
estimates the average erythrocyte volume and increased MCV serves 
Table 1: Therapeutic effect of rutin against HFD and 
alcohol‑induced hematological alterations
Groups RBC (103/mm3) RDW (%) HCT (%) MCV (μm3)
Group 1 7.51±0.58 16.6±1.58 52.1±3.70 33.05±2.79
Group 2 7.54±0.62 16.7±1.58 52.2±3.70 33.09±2.71
Group 3 6.59±0.62 14.8±1.33 37.3±2.82* 43.05±2.80*
Group 4 6.86±0.65 14.9±1.36 44.3±2.44 38.30±3.08
Group 5 6.91±0.62 15.1±1.04 49.5±2.84ɸ 36.10±2.92
Group 6 7.29±0.70 15.2±1.17 51.3±3.20ɸ 35.40±2.20ɸ
Group 7 7.24±0.67 15.0±1.03 48.5±2.99ɸ 37.30±2.95
ANOVA 0.37 0.45 3.59ω 1.83
Data are expressed as mean±SE; n=6; Significant ANOVA at ωp≤0.05. For 
Student’s t-test. Significant P value HFD+alcohol versus control *p≤0.05, and 
therapy versus HFD+alcohol Φp≤0.05. Group 1: Control; Group 2: Rutin per 
se (rutin 40 mg/kg); Group 3: HFD+alcohol; Group 4: HFD+alcohol+Rutin 
10 mg/kg; Group 5: HFD+alcohol+Rutin 20 mg/kg; Group 6: HFD+alcohol+Rutin 
40 mg/kg; Group 7: HFD+alcohol+Silymarin 50 mg/kg. RBC: Red blood cell, 
RDW: Red cell distribution width, HCT: Hematocrit, MCV: Mean corpuscular 
volume, HFD: High-fat diet, SE: Standard error
Table 2: Therapeutic effect of rutin against HFD and 
alcohol‑induced hematological alterations
Groups Hemoglobin (g/dl) MCH (pg) MCHC (g/dl)
Group 1 14.4±1.17 19.6±1.16 39.15±1.54
Group 2 14.1±1.29 19.4±1.02 39.19±2.95
Group 3 13.6±1.15 20.6±1.55 40.05±2.44
Group 4 13.7±1.13 20.4±1.54 39.10±2.79
Group 5 13.8±1.32 20.4±1.54 38.90±2.31
Group 6 14.0±1.27 19.9±1.24 38.70±2.96
Group 7 13.2±1.05 19.6±1.13 38.65±2.96
ANOVA 0.11 0.14 0.03
Data are expressed as mean±SE; n=6. Group 1: Control; Group 2: Rutin 
per se (rutin 40 mg/kg); Group 3: HFD+alcohol; Group 4: HFD+alcohol+Rutin 
10 mg/kg; Group 5: HFD+alcohol+Rutin 20 mg/kg; Group 6: 
HFD+alcohol+Rutin 40 mg/kg; Group 7: HFD+alcohol+Silymarin 50 mg/kg. 
MCH: Mean corpuscular hemoglobin, MCHC: Mean corpuscular hemoglobin 
concentration, HFD: High-fat diet, SE: Standard error
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as an indicator of macrocytosis [24]. Alcohol intoxication also led 
macrocytosis and thrombocytopenia by increasing MCV [25]. In the 
present study, combined consumption of HFD and alcohol increased 
MCV count which may lead to macrocytosis and thrombocytopenia. 
Rutin administration may reduce the chance of macrocytosis and 
thrombocytopenia by decreasing MCV [23].
White blood cell (WBC) counts are linked with insulin resistance, 
Type 2 diabetes [26], stroke, coronary artery disease [27], and 
diabetes micro- and macro-vascular complications [28]. Leukocytes 
are composed of polymorphonuclear cells such as lymphocytes and 
monocytes. Lymphocytes, polymorphonuclear, and mononuclear 
leukocytes can be activated by advanced glycation end products [29], 
oxidative stress [30], angiotensin II [31], and cytokines [32] in 
state of hyperglycemia. The present investigation showed that HFD 
and alcohol consumption altered TLC, monocyte, lymphocyte, and 
eosinophil count. Findings were in corroboration with previous 
studies [22,17]. Flavonoids containing bioactive compounds 
maintained WBC counts due to their free radical scavenging 
property [23,22]. It is reported that honey and royal jelly showed 
significant protective effect on hematological variables [33] because 
they contain several bioactive compounds. Rutin administration 
maintained these hematological variables might be due to their 
antioxidant activity [7].
CONCLUSION
The result of the present study concluded that rutin prevents 
deleterious changes in total WBC counts, HCT, platelet count, 
lymphocytes, eosinophil and monocyte in HFD, and alcohol-fed rats due 
to its effective free radical scavenging property. Rutin may be used as a 
therapeutic agent to combat blood toxicity.
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